ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,304 | -33.9% | 33,183 | +0.0% | 0.00% | -50.0% |
| Q2 2023 | $344,097 | +136446.4% | 33,182 | +6.5% | 0.00% | 0.0% |
| Q1 2023 | $252 | -99.9% | 31,144 | +157.6% | 0.00% | 0.0% |
| Q2 2022 | $169,000 | -11.1% | 12,090 | +14.7% | 0.00% | +33.3% |
| Q3 2021 | $190,000 | +258.5% | 10,539 | -49.2% | 0.00% | +50.0% |
| Q3 2020 | $53,000 | -44.2% | 20,750 | -64.7% | 0.00% | -60.0% |
| Q2 2020 | $95,000 | +55.7% | 58,726 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $61,000 | -45.0% | 58,726 | -0.3% | 0.01% | 0.0% |
| Q4 2019 | $111,000 | +73.4% | 58,926 | 0.0% | 0.01% | +150.0% |
| Q3 2019 | $64,000 | -32.6% | 58,926 | +356.6% | 0.00% | 0.0% |
| Q4 2018 | $95,000 | -68.6% | 12,906 | +5.0% | 0.00% | -75.0% |
| Q4 2017 | $303,000 | – | 12,296 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |